N2:BLR N2:CMPNY N2:DEAL1 N2:MRCH N2:MRCH1 N2:MRG N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PUBL N2:US Merck to build out immunology presence with $11 billion Prometheus dealBy Michael Erman (Reuters) -Merck & Co said on Sunday it will buy Prometheus Biosciences...
